公司资料

Treace Medical Concepts 股价、新闻与催化剂

股票代码:
TMCI
交易所:
NASDAQ
行业:
MedTech
所在地:
United States

股票表现

4.50 USD (-6.05%)

收盘价

最后更新: 2026年8月17日

225M USD

市值

股价为何变动

As of Aug 17, 2026, TMCI closed down 6.05% at $4.50. No new same-company headline was identified in the current news window.

公司概览

Bunion and Midfoot Surgery

Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy.

Lapiplasty Platform

The Lapiplasty procedure and associated instrumentation enable surgeons to correct and stabilize the metatarsal in multiple planes. Treace has expanded the platform with implants and tools covering a broader range of bunion presentations. The company sells single-use implants and instruments through a specialized field organization, supported by surgeon training and a growing installed base of reusable surgical equipment.

未来催化剂

    近期新闻

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。